Search for: "Lilly France" Results 21 - 40 of 135
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Aug 2017, 9:53 am
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle? [read post]
11 Jan 2012, 9:44 pm by Kristine Meredith
  Actos has been a huge success for Takeda, as Both Takeda  and Eli Lilly marketed the drug in Japan, the United States, France and Germany. [read post]
15 Jul 2017, 5:11 am
The summary stated that the Supreme Court allows Eli Lilly's appeal and holds that Actavis' products directly infringe Eli Lilly's patent in the United Kingdom, France, Italy and Spain. [read post]
19 Apr 2017, 2:21 am by Brian Cordery
Furthermore, Actavis requested DNIs from the UK court in relation to France, Spain and Italy as well as the UK. [read post]
23 Dec 2009, 12:40 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: Zyprexa (Olanzapine) – UK: Court of Appeal upholds Justice Floyd’s decision finding Olanzapine patent valid: Dr Reddy’s Laboratories v Eli Lilly (EPLAW) (IPKat) (Managing IP) (PatLit) (GenericsWeb) France: Pharma trade marks under threat - Senate and National Assembly approve law that would allow… [read post]
29 Jan 2018, 2:57 am
 The UCL debate on the UK Supreme Court decision Actavis v Eli Lilly ("Equivalents: K = Na. [read post]
4 Sep 2017, 1:16 pm
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle? [read post]
29 Jun 2015, 9:36 am
.* A novel becomes a saga - Actavis v Lilly set to go on and onThe IPKat blogged last year about the masterful and erudite judgment of Mr Justice Arnold in Actavis v Lilly (judgment on BAILII here), concerning pemetrexed. [read post]
18 Aug 2017, 5:56 am
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle? [read post]
28 May 2018, 7:53 am
Eli Lilly pemetrexed battles here, here and here. [read post]
13 Jul 2017, 8:47 am by Brian Cordery
Thirteen years after the House of Lords had firmly shut the door on any notion of a doctrine extending the scope of patent protection outside the claims, the UK Supreme Court in yesterday’s judgment in Actavis v Eli Lilly [2017] UKSC 48 reversed gear and reintroduced a true form of doctrine of equivalents into UK law. [read post]
13 Jul 2017, 8:47 am by Brian Cordery
Thirteen years after the House of Lords had firmly shut the door on any notion of a doctrine extending the scope of patent protection outside the claims, the UK Supreme Court in yesterday’s judgment in Actavis v Eli Lilly [2017] UKSC 48 reversed gear and reintroduced a true form of doctrine of equivalents into UK law. [read post]
23 Jan 2012, 6:58 am by Breakstone, White & Gluck
Actos is manufactured by Takeda Pharmaceutical Company and co-marketed by Eli Lilly and Company. [read post]
22 Jun 2007, 6:26 am
According the the MHRA the counterfeit product entered the British market through parallel market imports from France. [read post]
7 Mar 2016, 1:55 am
.* Online image search: does France think that the best way to help copyright owners is to deprive them of their rights? [read post]
3 Aug 2011, 3:31 am by Marie Louise
: Cour d’Appel Paris decision in Teva v Eli Lilly (Kluwer Patent Blog) US: CAFC confirms that isolated DNA may be patented: Association for Molecular Pathology v. [read post]